Puma Biotechnology | PBYI - Operating Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Puma Biotechnology

Puma Biotechnology reported $48.41M in Operating Expenses for its fiscal quarter ending in March of 2023.


Operating Expenses Change
Agios Pharmaceuticals AGIO:US USD 96.22M 120.59M
Alnylam Pharmaceuticals ALNY:US USD 469.1M 54.55M
Amgen AMGN:US USD 4.07B 538M
Biogen BIIB:US USD 1.96B 111.2M
BioMarin Pharmaceutical BMRN:US USD 537.07M 24.97M
Bluebird Bio BLUE:US USD -6056000 19.32M
Daiichi Sankyo 4568:JP JPY 336.75B 27.83B
Esperion Therapeutics ESPR:US USD 72.93M 11.6M
Exelixis EXEL:US USD 379.96M 92.04M
Gilead Sciences GILD:US USD 4.65B 475M
Glaxosmithkline GSK:US GBP 4.87B 640M
Incyte Corp INCY:US USD 783.9M 72.7M
Intercept Pharmaceuticals ICPT:US USD 99.59M 4.35M
MacroGenics MGNX:US USD 62.92M 1.81M
Mirati Therapeutics MRTX:US USD 200.99M 11.67M
Moderna Inc MRNA:US USD 2.23B 1.28B
Novartis NOVN:VX USD 10.35B 700M
Pfizer PFE:US USD 11.5B 7.63B
PTC Therapeutics PTCT:US USD 338M 29.76M
Puma Biotechnology PBYI:US USD 48.41M 19.61M
Regeneron Pharmaceuticals REGN:US USD 2.22B 52.2M
Roche Holding ROG:VX 25.06B 4.31B
Sangamo BioSciences SGMO:US USD 139.92M 57.3M
Sarepta Therapeutics SRPT:US USD 778.92M 411.08M
Seattle Genetics SGEN:US USD 704.23M 22.08M
Spectrum Pharmaceuticals SPPI:US USD 20.48M 1.27M
Takeda 4502:JP JPY 867.59B 81.97B
TG Therapeutics TGTX:US USD 44.79M 7.35M
Ultragenyx Pharmaceutical RARE:US USD 254.6M 5.62M
Vanda Pharmaceuticals VNDA:US USD 60.49M 2.64M
Vertex Pharmaceuticals VRTX:US USD 1.6B 326.6M